Rinki Kapoor Email & Phone Number

New York, Ny, Us

Waltham, Ma, Us

Boston, Ma, Us

Chicago, Il, Us

• Commercial Launch: Led and successfully completed a commercial launch of an orphan drug with a $1B market opportunity, for the treatment of small cell lung cancer at a record speed of 5 months from NDA filing to approval• Launch Planning: Spearheaded Navigant’s global collaboration with the executives of a pharmaceutical company for an accelerated commercial US drug launch of their asset with a target addressable market of $200M, within 1-year of initiating Phase 3 clinical trial• Growth Strategy: Led a team of five to develop the growth strategy of an oncology start-up; resulted in discovering a $2B global opportunity across major tumors • Product Planning: Managed an international team to assess the business potential of a multinational diagnostic company’s technology platform in sexually transmitted diseases; led to identifying $1B annual opportunity in the US • Product Commercialization: Developed a product commercialization strategy for a $20B pharmaceutical company for their software as a medical device (SaMD) for mental health disorders; delivered a roadmap of customer segments and identified critical success factors for commercialization • Thought Leadership: Published 2 articles in Cell & Gene on “market access & reimbursement”, and on “strategies for success” of the groundbreaking CAR-T therapy in oncology

Chicago, Il, Us

• Strategic Planning: Developed a ten year business unit strategic plan for a $5B hematology portfolio for a global pharmaceutical company; resulted in a projected 60% portfolio growth over ten years • Growth Strategy: Created life cycle management strategy for an anti-thrombotic drug marketed by a top ten pharmaceutical company; identified a $10B growth opportunity across ten disease areas • Launch Planning: Developed a global launch playbook for a large pharmaceutical client to ensure launch excellence for commercial planning; deliverable being utilized cross-functionally across all the client’s cell therapy assets

• Leading the assay development for early diagnosis of invasive fungal infections, that have mortality rates approaching 40% • Analyzing clinical data to demonstrate the benefits of early diagnosis to doctors • Coordinating across multi-functional team to meet project milestones, and driving project presentations at project review and company meetings• Managing multiple clinical collaborators providing samples • Successfully preparing project plans, defining timelines, monitoring workflow, and ensuring deadlines are metSignificant Achievements • One of 6 scientists selected from 900+ applicants to present at the annual AACC meeting, the leading conference in clinical chemistry (2014)• Selected to present at the ASM Microbe conference; the #1 ranked conference in microbiology (2016)

• Designed a microfluidics assay and increased the diagnostic sensitivity by 100x• Established a system to express recombinant proteins, increased the yield by 30x, to enable successful characterization • Developed analytical assays (HPLC and CE) for protein purification and characterization• Identified and successfully transferred procedures to CRO/CMO’s

Stanford, Ca, Us

• Developed a model to treat chronic wound infections that results in an annual healthcare expenditure of $20 billion • Advanced the current treatment regime by investigating rapid and sensitivity antimicrobials

Stanford, Ca, Us

• Designed and studied novel antimicrobials to prevent and treat multi-drug resistant bacterial infections, a leading threat to public health worldwide • Improved antimicrobials by designing novel drugs with 30-times higher efficacy than currents antibiotics • Mentored undergraduate and summer students, assisted them with designing and implementing laboratory experiments and fellowship writing Significant Achievements • Published 4 peer-reviewed articles in leading microbiology journals (2011 - 2012)• Presented at 2 invited talks and 7 additional international conferences (2008 - 2011)

Gurgaon, Haryana, In

• Synthesized and characterized an anti HIV drug “Tenofovir Disoproxil Fumarate”

Phd, Biophysics

Certificate Course, Product Management: Art And Science Of Building Great Products

Doctor Of Philosophy (Ph.D.), Organic Chemistry

M.Sc., Organic Chemistry

B.Sc, Chemistry